Viregyt-K

Viregyt-K contains amantadine hydrochloride, an antiviral and antiparkinsonian agent used to treat influenza A and manage Parkinson's disease symptoms. This oral medication is available in EU markets and requires careful adherence to prescribed instructions.

Amantadine hydrochloride, the active ingredient in Viregyt-K, is primarily used to treat and prevent influenza A virus infections. It is also prescribed to help manage symptoms of Parkinson's disease, such as tremors and muscle stiffness, by influencing dopamine activity in the brain.

Viregyt-K works by blocking viral replication in influenza A cases and modulating dopamine pathways for Parkinson's symptom relief. Users may experience improved mobility and reduced tremors with consistent use. Some individuals report mild central nervous system effects like dizziness or lightheadedness.

Store Viregyt-K at room temperature away from moisture and direct light. Keep this medication out of reach of children and pets. Inform your healthcare provider about any existing medical conditions, especially kidney problems or mental health disorders, before starting this medication.

Viregyt-K may interact with other medications affecting the central nervous system, such as sedatives or antidepressants. Alcohol and other substances that cause drowsiness should be avoided while taking this drug. Consult a healthcare professional before combining with prescription or over-the-counter products.